# RAE (Realize, Analyze, Engage)

> **NCT05227339** · PHASE2,PHASE3 · COMPLETED · sponsor: **ContinueYou, LLC** · enrollment: 209 (actual)

## Conditions studied

- Substance Use Disorders
- Treatment Adherence and Compliance

## Interventions

- **DEVICE:** RAE

## Key facts

- **NCT ID:** NCT05227339
- **Lead sponsor:** ContinueYou, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-22
- **Primary completion:** 2024-02-01
- **Final completion:** 2024-04-01
- **Target enrollment:** 209 (ACTUAL)
- **Last updated:** 2024-07-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05227339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05227339, "RAE (Realize, Analyze, Engage)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05227339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*